Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research

Quality indicators for palliative and end of life care: a review of Swedish policy documents Susanne Lind,1 Jan Adolfsson,2 Bertil Axelsson,3,4 Carl Johan Fürst5,6

1

Palliative Research Centre, Ersta Sköndal University College and Ersta Hospital, Stockholm, Sweden 2 Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden 3 Department of Radiation Sciences, University of Umeå, Umeå, Sweden 4 FoU unit, Östersunds Hospital, Östersund, Sweden 5 Department of Oncology– Pathology, Karolinska Institutet, Stockholm, Sweden 6 Department of Clinical Sciences, Lund University, Lund, Sweden Correspondence to S Lind, Palliative Research Centre, Ersta Sköndal University College and Ersta Hospital, Stockholm S 100 61, Sweden; [email protected] Received 16 October 2012 Revised 2 February 2013 Accepted 8 February 2013 Published Online First 6 March 2013

To cite: Lind S, Adolfsson J, Axelsson B, et al. BMJ Supportive & Palliative Care 2013;3:174–180.

174

ABSTRACT Background All patients with palliative and end of life care needs should be guaranteed equal and safe treatment and care, regardless of their disease or site of care. The inclusion of quality indicators in national guidelines and other guiding documents supports quality assurance and improvement in provision of care. The aim of this paper was to review existing quality indicators in national Swedish policy documents relevant to palliative and end of life care. Methods We reviewed existing guidelines for diseases expected to require palliative care issued by the National Board of Health and Welfare, existing regional clinical practice guidelines and the annual report of the Swedish Register of Palliative Care (SRPC) up until 2010. Results We found 11 quality indicators pertinent to palliative and end of life care in the guidelines for cancer diseases and ‘The care and nursing of the elderly’. The indicators included assessment and treatment of pain, communication with the patient and the family, documentation in the patient record and registration in the SRPC. In the national guidelines for cardiology, pulmonary diseases, stroke, diabetes and dementia, there were no indicators relevant for palliative or end of life care. Conclusions In the existing Swedish national guidelines for many different diseases, there is still a great need to define clinically relevant and feasible outcome measures of quality of palliative and end of life care.

INTRODUCTION All patients with palliative care needs should be guaranteed equal and safe treatment and care, regardless of their disease or site of care. This accords with the general aim of Swedish law, as laid down by a government commission, and it is stipulated as a basic human right.1–3 Work began on national clinical practice

guidelines for palliative care in Sweden in 2009, with the goal of providing a commonly agreed upon knowledge base, and the first official version was published in March 2012.4 Quality indicators (QIs) are increasingly used to assess the quality of palliative care. Indicators and their measurement are not always well defined and vary on disease and care contexts. We conducted a review of existing QIs in national Swedish policy documents relevant to palliative care and end of life care. How does the Swedish health care system define ‘quality’?

The word ‘quality’ describes a property5 but the meaning of this word has expanded in recent years such that ‘quality’ now refers to the ability of an object or a service to satisfy the needs and expectations of the customer, from various perspectives. The National Board of Health and Welfare (NBHW) defines ‘quality’ as ‘the degree to which a medical service satisfies the requirements placed on it’.6 The concept of ‘good care’ was launched in association with the publication of these regulations and general guidelines. Six quality domains were described as important and require health services and medical care to be knowledge based and appropriate, safe, patient focused, efficient, equitable and timely (box 1).7 The concept of ‘good care’ also requires palliative care to be provided throughout the healthcare system. How is quality measured in the Swedish health care system?

A QI structures the work of quality assurance. The NBHW and the Swedish Association of Local Authorities and Regions use the following definition: ‘A quality indicator is a measure that

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research Box 1 Descriptions of the six domains of ‘good care’, as specified by the National Board of Health and Welfare7 8

Table 1 Definition of measures, as specified by the National Board of Health and Welfare, and the Swedish Association of Local Authorities and Regions9 Definition

▸ “Knowledge based healthcare that is fit for the purpose means that the care is to be science and evidence based, and designed to meet the needs of the individual patient in the best possible way.” ▸ “Safe health and medical care means that medical errors are prevented through an active programme of risk prevention.” ▸ “A patient focused health and medical care means that care is given with respect and sensitivity to the specific needs of the individual, and his or her expectations and values. These are to be considered when making clinical decisions.” ▸ “The term efficient health and medical care is used to denote the use of the available resources in the best possible manner, in order to achieve the goals that have been set. This means that the care is designed and provided in collaboration with stakeholders in the healthcare system, based on the degree of severity of the condition and the cost effectiveness of the measures.” ▸ “Equitable health and medical care means that the care is provided and distributed based on equal considerations for all.” ▸ “Health and medical care within reasonable time means that no patient needs to wait an unreasonable time for the care that he or she needs.”

reflects quality and that can be used as the basis for operational development and for reporting the quality of health care’.9 The process of developing and using common QIs within specific domains will allow auditors to track the work and development of a single care unit, and to also measure and evaluate the care provided in a broader perspective. ‘Good care’ in the relevant context must be defined before QIs with quantitative measures can be developed. In order to be reliably measured, the QI should be scientifically reasonable and valid, and clearly defined.9 The metrics used to measure quality within the healthcare field are structure, process and outcome based. The goal is to measure the preconditions for good healthcare, the provision of care itself, including when, where and how it is provided, and the outcome of the care on the health and well being of patients (table 1).9 QIs may refer to either general or specific actions taken by healthcare providers. A general action is one that is ‘valid for all types of health and medical care or nursing, independent of the disease or patient group or the specific actions taken’, and will be measured as a general QI, while a specific action is ‘related to a specific disease group or requirements

Structure measure Process measure

Outcome measure

Reflects the preconditions available for good health and medical care/nursing Reflects the actual measures taken in care and nursing, when, where and how

Reflects the results and effects of care and nursing on health and well being

Example from existing guidelines A nurse educated in diabetes care10 The time that passes between the decision to treat and the therapeutic action for newly discovered cancer11 Lethality (the fraction of patients who die) from myocardial infarction12

group, or to a specific action taken’, and will be measured as a specific QI.9 The indicators can be placed into a matrix with, among other things, a description of what is to be measured, which measurement method is to be used and how the result is to be reported. In addition, the quality domain that the indicator is connected to is also specified (box 1), along with the link in the chain of care to which it is related (table 2).9 Palliative care, like any other type of care, must satisfy the requirements for good care. Patients with palliative care needs are found in almost every healthcare setting, and this variety of places of care is one of the challenges to develop relevant indicators. There have been several attempts to define QIs for palliative care through methodologies using expert opinions as well as through bereaved family members.13–15 In 2009, work began on national clinical guidelines for palliative care in Sweden and a chapter about QIs was included. A research question was formulated during the work: ‘Which QIs for palliative care and end of life care are described in existing national policy documents in Sweden?’ MATERIALS AND METHODS The report ‘National indicators of good care’,8 which describes indicators in published national guidelines, preliminary proposals and ongoing work, was reviewed to identify QIs for palliative care and end of life care. Guidelines for eight specific diseases10–12 16–18 and one overall guideline for cancer care11 were estimated as relevant for inclusion, as they related to diseases that are likely to lead to death. A manual search on the NBHW website in April 2010 showed one further guideline relevant to the question.19 A document describing QIs specific for the elderly20 was also included. It is recognised as a national guideline in the result. The report entitled ‘End of life care’, published by the NBHW in 2006,21 was reviewed, especially the chapter describing existing regional and local clinical practice guidelines. Nine guidelines were identified,

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

175

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research Table 2 Definition of a quality indicator, as specified by the National Board of Health and Welfare, and the Swedish Association of Local Authorities and Regions9

Content

Measure

Description

Measurement method

Data source

Source of error

Definition of the indicator in measurable terms

Description of numerator and denominator

Description of data collection method

Description of data source

Specification of any sources of error

two including palliative care for cancer patients. The other seven concern palliative care for any diagnosis. The care guidelines had been published and/or revised between 2002 and 2006. We searched for revisions and updates of the specified guidelines, contacting responsible individuals through email and telephone in May 2010. Two revised and one new regional clinical practice guideline were found (figure 1). The annual report for 2010 for the Swedish Register of Palliative Care (SRPC)22 was also reviewed. In our review, a national guideline is defined as a document published by the government, in this case the NBHW, while clinical practice guidelines are written by the medical and nursing profession with knowledge in the field of palliative care. QIs were included whether or not they were described with a numerator and denominator. In the present report, it was not considered relevant to make a distinction between the concepts of palliative care and end of life care. Since the review was performed, two new documents have been published in 2012: ‘A national knowledge based guidance for good palliative care’ including national guidelines ( preliminary version) from the NBHW23 and ‘National clinical practice guidelines for palliative care 2012–20144’. They are not included in the result, but in the discussion section.

Reporting Description of how data should be reported

Target level Description of target levels

Stakeholder Which quality area (s) and which stage (s) the indicator relates to, and who the stakeholder is

RESULTS QIs for palliative care and end of life care in national guidelines published by the NBHW

The total number of QIs found in the searched documents was 240, and of these 11 were distinct quality palliative care indicators (table 3). The palliative QIs were found in the five guidelines for cancer diseases and ‘The care and nursing for elderly’. Numerator and denominator were described for seven of them. The QIs relevant to palliative care and end of life care from the national guidelines are presented in their original wording (table 4). There were 43 QIs specifically for cancer, but none of the QIs regarding breast cancer or colorectal cancer where relevant for palliative care. One of the seven indicators for prostate cancer was described as specific palliative—that is, the proportion offered radiation therapy for painful skeletal metastases. For lung cancer there were 26 indicators, three of which were specific for palliative lung cancer care. In addition to the cancer specific QIs, there were 10 overall indicators for cancer care, three of which were explicitly referred to end of life care: pain assessment, prescription of opioid for pain relief during end of life care and registration of deaths in SRPC. All guidelines for cancer diseases referred to these. Furthermore, the

Table 3 Quality indicators for palliative care from the guidelines of the National Board of Health and Welfare, and from ‘Care and nursing of the elderly’ National guideline Asthma and COPD 200419 Breast cancer care 200711 Cardiac care 200812 Care and nursing of the elderly 200920 Colorectal cancer care 200711 Dementia care 200917 Diabetes care 201010 Lung cancer care 201018 Overall indicators for cancer care 200711 Prostate cancer care 200711 Stroke care 200916

No of QIs explicitly for palliative care and end of life care

0 3 general and common for cancer 0 3 3 general and common for cancer 0 0 4+3 general and common for cancer 3 general and common for cancer 1+3 general and common for cancer) 0 n=11 (8 different QIs+3 general and common for cancer) COPD, chronic obstructive pulmonary disease; QI, Quality indicators.

176

Total No of QIs, including development indicators (n=240) 52 5 41 18 7 20 24 26 10 5 32 n=240

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research Table 4 Quality indicators for palliative care as described in national guidelines for breast, colorectal and prostate cancer care (including overall indicators for cancer care),11 national guidelines for lung cancer care18 and national quality indicators, and ‘Care and nursing of the elderly’20 Found in national guidelines/national Specific indicators for palliative care (translated verbatim) quality indicators

Measure referred to numerator/ denominator

Age normalised incidence of palliative radiation therapy for skeletal metastases in prostate cancer Palliative radiation therapy for incurable lung cancer

Prostate cancer care

Process measure

Lung cancer care

Palliative chemotherapy for lung cancer

Lung cancer care

Stent in case of vena cava superior syndrome General indicators for palliative care Guidelines and procedures used for end of life care and nursing that describe, among other things, how informed counselling can be offered to terminally ill people aged 65 years and older Fraction of people aged 65 years and older who have died, for whom pain was estimated with the aid of a scientifically evaluated instrument such as an NRS or a VAS, during the final week of life Fraction of relatives offered counselling for survivors

Lung cancer care

Process measure Numerator and denominator described Process measure Numerator and denominator described Process measure

Quality area referred to Patient focused health and medical care Equitable care

Equitable care

Equitable care

Care and nursing of the elderly

Not specified

Patient focused health and medical care

Care and nursing of the elderly

Not specified Numerator and denominator described

Patient focused health and medical care

Care and nursing of the elderly

Not specified Numerator and denominator described Structure and process measure Numerator and denominator described

Patient focused health and medical care

Process measure Numerator and denominator described

Knowledge based health and medical care that is fit for purpose

Process measure Numerator and denominator described

Safe health and medical care, and patient focused health and medical care

Process measure

Patient focused health and medical care

Use of an NRS (1–10) for pain estimation during the palliative phase

Overall indicators for cancer care Breast, colorectal and prostate cancer care Lung cancer care Registration of deaths in Swedish Register of Palliative Care Overall indicators for cancer care Breast, colorectal and prostate cancer care Lung cancer care Prescription of opioid administered parenterally as required, for Overall indicators for pain relief during end of life care cancer care Breast, colorectal and prostate cancer care Lung cancer care Documentation of the patient’s transition to the palliative phase Lung cancer care (development indicator) NRS, numeric rating scale; VAS, visual analogue scale.

measure ‘Documentation of the patient’s transition to palliative care’ was suggested as a development indicator in the guideline for lung cancer because of the importance for both patient and caregiver to be aware of the transition from life prolonging treatment to palliative care. The document ‘Care and nursing of the elderly’ contained 18 QIs, three of which are used explicitly during the palliative phase. None of the remaining five national guidelines included indicators that could be applied to palliative care (table 4). QIs for palliative care in regional clinical practice guidelines for palliative care

The most common indicator in regional clinical practice guidelines for palliative care was registration in the SRPC. As part of the report published by the

Knowledge based health and medical care that is fit for purpose

NBHW ‘End of life care’,21 county councils and regions were questioned about the availability of clinical practice guidelines for palliative care. Nine were identified, two of which comprised palliative care for cancer patients. The other seven concerned palliative care for any diagnosis. The guidelines had been published and/or revised between 2002 and 2006. The report from the NBHW21 concluded that only one of the guidelines, ‘VILA, Clinical guideline for the Mölndal area’,24 addressed follow-up and development of quality. The guideline has a chapter with suggestions on standards for quality measures, such as pain assessment. Numerator and denominator were not defined for the QIs. The search for revisions and updates in May 2010 showed two revised and one new regional clinical practice guideline. One of the revised guidelines

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

177

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research

Figure 1

Flowchart of the search for quality indicators. NBHW, National Board of Health and Welfare.

recommended registration in the SRPC as a QI and the other one had no quality indicator. The new clinical guideline25 recommended the same overall QIs as for cancer diseases, explicitly referred to end of life care: pain assessment, prescription of opioid for pain relief during end of life care and registration of deaths in the SRPC. QIs for palliative care in the SRPC

The SRPC was established in 2005 as a national quality register with the aim of improving end of life care across all domains by identifying areas in which the quality of care can be improved. Registration takes place online after the death of the patient and is intended to reflect the quality of care during the patient’s last days or weeks.22 The SRPC annual report for 2010 included the three QIs for palliative care and end of life care that apply to all types of cancer care as well as the general indicators described in ‘Care and nursing of the elderly’.20 The QIs were: the patient and the relatives have been informed of the situation, the patient’s pain and other symptoms have been relieved, injectable medication is available, the patient has been given the opportunity to die in a 178

place of his or her choosing and does not need to die alone, and the relatives have been offered bereavement counselling/support. Numerator and denominator were not defined for the QIs in the report. DISCUSSION In our review of Swedish policy documents, we identified 11 QIs for palliative care and end of life care out of a total of 240. Of these, three were explicitly related to end of life care: use of a numeric rating scale (NRS) for assessment of pain, registration in the SRPC and prescription of an injectable opioid as required. Disease specific indicators for palliative care are increasingly being described for various types of cancer, as related to specific therapeutic interventions. It is questionable if the suggested interventions (radiation therapy, chemotherapy and stent) (table 4) are disease specific QIs and if they are relevant for end of life care. However, it is a positive trend that measures for palliative care are described in guidelines for specific diseases. Palliative care is also addressed through analysis of the care of the elderly using three indicators, mainly related to information to be given to the patient and the family but also assessment of pain. In the

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research national guidelines for cardiology, pulmonary diseases, stroke, diabetes and dementia, there were no indicators relevant for palliative care or end of life care. Quite a few of the QIs in the Swedish guidelines (11/240) are relevant for palliative care and end of life care, but it is more than Raijmakers et al26 found in their update of national guidelines. In the national guidelines of four countries, they found one QI relevant for care of cancer patients in their last days of life. One explanation is probably their definition of a QI (it should contain a numerator, denominator, cut-off point and address care in the last days of life) while our inclusion was much broader. One of the described indicators, pain assessment by NRS, is specified as both a process and a structure indicator, while the others relate to process indicators. NRS for pain can also be used as a measure for an outcome indicator. This confirms the results of two international reviews of QIs for palliative care (by Ostgathe and Voltz,27 and by Pasman et al.28 Pasman et al found 142 palliative care indicators, most of which were process indicators with 57 outcome measures (two related to both process and outcome). Only five were structure measures. Both Pasman et al and Ostgathe and Voltz use the eight domains that the National Consensus Project29 has defined as important at the end of life. Most of the measures described in the reviews27 28 reveal the physical, structural and process aspects of the care. This is consistent with the above results. There is a tendency to classify palliative care indicators in different ways in the documents that have been examined. Pain assessment, for example, which is found in two documents, relates to knowledge based and appropriate health and medical care in one case, and in another to the quality area of patient focused health and medical care.11 20 During 2012, the NBHW published ‘A national knowledge based guidance for good palliative care’ including national guidelines (preliminary version).23 They suggest nine QIs, six of which are possible to measure today. One QI is specified as a structure indicator (registration in the SRPC) and one as an outcome indicator (assessment of oral health). The remaining four are described as process indicators: two or more inpatient care admissions during the past 30 days, occurrence of pressure ulcers, prescription of opioid as required and prescription of anxiolytic as required. According to Raijmakers et al,26 an expert panel rated avoiding inpatient care during the past 30 days as a good descriptor of quality of care in the last days of life. National clinical practice guidelines for palliative care 2012–20144 was published in March 2012, before the document from the NBHW, and refer to the SRPC and the general QIs for palliative care and end of life care in existing guidelines. Hopefully relevant indicators for end of life care can be described in more detail in the next version of the clinical practice guidelines.

The proposals of the SRPC, the national clinical practice guidelines for palliative care 2012–2014,4 ‘A national knowledge based guidance for good palliative care’ (preliminary version),23 the results of the present work and the articles by Ostgathe and Voltz27 and Pasman et al28 are consistent, and suggest that the development of general palliative care indicators in Sweden would lead to specification and validation of the existing indicators so that they become useful within care and nursing, across all diseases and sites of care. New indicators should be developed gradually, mainly within the areas that currently lack any indicators, such as the social and cultural aspects of care. We hope that such a development will inspire further work with specific palliative care measures within diseases other than cancer. CONCLUSION There is a lack of clinically relevant and feasible QIs for palliative care and end of life care in existing Swedish national guidelines for many different diseases. To increase the quality of care in a patient as well as from a caregiver and organisational perspective, it is important to continue the work to develop and define general as well as specific QIs. This is relevant for different palliative care contexts, including a variety of diseases other than cancer and geriatric conditions. National and international consensus would support the opportunity to benchmark and exchange experience. Contributors All authors were part of the conception

and design of the study (SL and CJF), or analysis and interpretation of the data (SL, CJF, JA and BA), drafting the article or revising it critically for important intellectual content (SL, CJF, JA and BA), and final approval of the version to be published (SL, CJF, JA and BA). Competing interests None. Provenance and peer review Not commissioned; externally peer reviewed.

REFERENCES 1 Kommittén om vård i livets slutskede (Committee for end-of-life care). Döden angår oss alla: värdig vård vid livets slut: slutbetänkande (death concerns us all: end-of-life care with dignity. Final report). Stockholm: Fritzes offentliga publikationer, 2001. 2 De Lima L, Krakauer EL, Lorenz K, et al. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manage [Research Support, U.S. Gov’t, Non-P.H.S.] 2007;33:521–6. 3 Brennan F. Palliative care as an international human right. J Pain Symptom Manage 2007;33:494–9. 4 Regionalt cancercentrum Stockholm Gotland. (Regional cancer center Stockholm Gotland.) Nationellt vårdprogram för palliativ vård 2012–2014. (National clinical practice guidelines for palliative care 2012–2014.) Ed. Regionala cancercentrum i samverkan. (Ed. Regional cancer center in cooperation.) Västerås: Edita, 2012;1–119.

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

179

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Research 5 Nationalencyklopedin (The Swedish National Encyclopaedia) [database on the Internet]. http://www.ne.se/kvalitetsindikator (accessed 5 Aug 2010). 6 National Board of Health and Welfare. SOSFS 2005:12 (M) Ledningssystem för kvalitet och patientsäkerhet i hälso-och sjukvården. (Management systems for quality and patient safety within the health and medical care system). 2005. 7 National Board of Health and Welfare. God vård—om ledningssystem för kvalitet och patientsäkerhet i hälso- och sjukvården (Good care—management systems for quality and patient safety within the health and medical care system). 2006. 8 National Board of Health and Welfare. Nationella indikatorer för God vård—Hälso- och sjukvårdsövergripande indikatorer— Indikatorer i Socialstyrelsens nationella riktlinjer (National indicators for good care—comprehensive indicators in health and medical care—indicators in the national guidelines published by the National Board of Health and Welfare). 2009. 9 National Board of Health and Welfare, and Swedish Association of Local Authorities and Regions. Modell för utveckling av kvalitetsindikatorer Rapport från Info-VU-projektets nätverk för kvalitetsindikatorer (Model for development of quality indicators: Report from the Info-VU project’s network for quality indicators). 2005. 10 National Board of Health and Welfare. Nationella riktlinjer för diabetesvården 2010, Indikatorer, Bilaga 2 (National guidelines for diabetes care 2010, Indicators, Appendix 2). 2010. 11 National Board of Health and Welfare. Nationella riktlinjer för bröst-, kolorektal- och prostatacancersjukvård, Beslutsstöd för prioriteringar (National guidelines for breast, colorectal and prostate cancer care: Decision support for setting priorities). 2007. 12 National Board of Health and Welfare. Nationella riktlinjer för hjärtsjukvården Bilaga 4 till beslutsstödsdokumentet— Kvalitetsindikatorer (National guidelines for cardiac care, Appendix 4 to the decision-support document, Quality indicators). 2008. 13 Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol [Research Support, U.S. Gov’t, P.H.S. Review] 2003;21:1133–8. 14 Grunfeld E, Urquhart R, Mykhalovskiy E, et al. Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer [Research Support, Non-U.S. Gov’t] 2008;112:2301–8. 15 Miyashita M, Morita T, Ichikawa T, et al. Quality indicators of end-of-life cancer care from the bereaved family members’ perspective in Japan. J Pain Symptom Manage [Research Support, Non-U.S. Gov’t] 2009;37:1019–26. 16 National Board of Health and Welfare. Nationella riktlinjer för strokesjukvård 2009—Indikatorer Bilaga 2 (National guidelines for stroke care 2009, Indicators, Appendix 2). 2009.

180

17 National Board of Health and Welfare. Indikatorer, Nationella riktlinjer för vård och omsorg vid demenssjukdom, Bilaga 5, Preliminär version (Indicators, National guidelines for care of those with dementia, Appendix 5, Preliminary version). 2009. 18 National Board of Health and Welfare. Indikatorer, Nationella riktlinjer för lungcancervård 2010—preliminär version, Bilaga 2 (Indicators, national guidelines for lung cancer care— preliminary version, Appendix 2). 2010. 19 National Board of Health and Welfare. Socialstyrelsens riktlinjer för vård av astma och kronisk obstruktiv lungsjukdom (KOL), Faktadokument och beslutsstöd för prioriteringar. (The National Board of Health and Welfare guidelines for the care of asthma and chronic obstructive pulmonary disease (COPD). Factual document and decision support for setting priorities). 2004. 20 National Board of Health and Welfare. Nationella kvalitetsindikatorer, Vården och omsorgen om äldre personer (National quality indicators; Care and nursing of the elderly). 2009. 21 National Board of Health and Welfare. Vård i livets slutskede, Socialstyrelsens bedömning av utvecklingen i landsting och kommuner (End-of-life care: The assessment by the National Board of Health and Welfare of developments in county councils and municipalities). 2006. 22 Swedish Register of Palliative Care. Årsrapport för Svenska Palliativregistret verksamhetsåret 2010 (Annual report for Swedish Register of Palliative Care, 2010). 2011. 23 National Board of Health and Welfare. Nationellt kunskapsstöd för god palliativ vård, preliminär version. (A national knowledge-based guidance for good palliative care, preliminary version). 2012. 24 Region Västra Götaland. VILA, Vårdprogram 2006 område Mölndal, Västra Götalandsregionen. Clinical guideline for the Mölndal area. 2006. 25 Östergötland County Council. Basal palliativ vård i Östergötland. Östergötlands läns landsting. Palliative care in Östergötland. 2009. 26 Raijmakers N, Galushko M, Domeisen F, et al. Quality indicators for care of cancer patients in their last days of life: literature update and experts’ evaluation. J Pall Med 2012;15:308–16. 27 Ostgathe C, Voltz R. Quality indicators in end-of-life care. Curr Opin Support Palliat Care 2010;4:170–3. 28 Pasman HR, Brandt HE, Deliens L, et al. Quality indicators for palliative care: a systematic review. J Pain Symptom Manage [Research Support, Non-U.S. Gov’t Review] 2009; 38:145–56. 29 Clinical practice guidelines for quality palliative care 2009, 2nd edn. http://www.nationalconsensusproject.org (accessed 9 Aug 2010).

Lind S, et al. BMJ Supportive & Palliative Care 2013;3:174–180. doi:10.1136/bmjspcare-2012-000390

Downloaded from http://spcare.bmj.com/ on September 19, 2015 - Published by group.bmj.com

Quality indicators for palliative and end of life care: a review of Swedish policy documents Susanne Lind, Jan Adolfsson, Bertil Axelsson and Carl Johan Fürst BMJ Support Palliat Care 2013 3: 174-180 originally published online March 6, 2013

doi: 10.1136/bmjspcare-2012-000390 Updated information and services can be found at: http://spcare.bmj.com/content/3/2/174

These include:

References Email alerting service

This article cites 8 articles, 1 of which you can access for free at: http://spcare.bmj.com/content/3/2/174#BIBL Receive free email alerts when new articles cite this article. Sign up in the box at the top right corner of the online article.

Notes

To request permissions go to: http://group.bmj.com/group/rights-licensing/permissions To order reprints go to: http://journals.bmj.com/cgi/reprintform To subscribe to BMJ go to: http://group.bmj.com/subscribe/

Quality indicators for palliative and end of life care: a review of Swedish policy documents.

All patients with palliative and end of life care needs should be guaranteed equal and safe treatment and care, regardless of their disease or site of...
214KB Sizes 0 Downloads 3 Views